5
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Inherited Cardiomyopathies and the Role of Mutations in Non-coding Regions of the Genome

      review-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Cardiomyopathies (CMs) are a group of cardiac pathologies caused by an intrinsic defect within the myocardium. The relative contribution of genetic mutations in the pathogenesis of certain CMs, such as hypertrophic cardiomyopathy (HCM), arrythmogenic right/left ventricular cardiomyopathy (ARVC) and left ventricular non-compacted cardiomyopathy (LVNC) has been established in comparison to dilated cardiomyopathy (DCM) and restrictive cardiomyopathy (RCM). The aim of this article is to review mutations in the non-coding parts of the genome, namely, microRNA, promoter elements, enhancer/silencer elements, 3′/5′UTRs and introns, that are involved in the pathogenesis CMs. Additionally, we will explore the role of some long non-coding RNAs in the pathogenesis of CMs.

          Related collections

          Most cited references81

          • Record: found
          • Abstract: found
          • Article: found
          Is Open Access

          PhyloCSF: a comparative genomics method to distinguish protein coding and non-coding regions

          Motivation: As high-throughput transcriptome sequencing provides evidence for novel transcripts in many species, there is a renewed need for accurate methods to classify small genomic regions as protein coding or non-coding. We present PhyloCSF, a novel comparative genomics method that analyzes a multispecies nucleotide sequence alignment to determine whether it is likely to represent a conserved protein-coding region, based on a formal statistical comparison of phylogenetic codon models. Results: We show that PhyloCSF's classification performance in 12-species Drosophila genome alignments exceeds all other methods we compared in a previous study. We anticipate that this method will be widely applicable as the transcriptomes of many additional species, tissues and subcellular compartments are sequenced, particularly in the context of ENCODE and modENCODE, and as interest grows in long non-coding RNAs, often initially recognized by their lack of protein coding potential rather than conserved RNA secondary structures. Availability and Implementation: The Objective Caml source code and executables for GNU/Linux and Mac OS X are freely available at http://compbio.mit.edu/PhyloCSF Contact: mlin@mit.edu; manoli@mit.edu
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            The structural basis for 14-3-3:phosphopeptide binding specificity.

            The 14-3-3 family of proteins mediates signal transduction by binding to phosphoserine-containing proteins. Using phosphoserine-oriented peptide libraries to probe all mammalian and yeast 14-3-3s, we identified two different binding motifs, RSXpSXP and RXY/FXpSXP, present in nearly all known 14-3-3 binding proteins. The crystal structure of 14-3-3zeta complexed with the phosphoserine motif in polyoma middle-T was determined to 2.6 A resolution. The bound peptide is in an extended conformation, with a tight turn created by the pS +2 Pro in a cis conformation. Sites of peptide-protein interaction in the complex rationalize the peptide library results. Finally, we show that the 14-3-3 dimer binds tightly to single molecules containing tandem repeats of phosphoserine motifs, implicating bidentate association as a signaling mechanism with molecules such as Raf, BAD, and Cbl.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              14-3-3 proteins: structure, function, and regulation.

              The 14-3-3 proteins are a family of conserved regulatory molecules expressed in all eukaryotic cells. A striking feature of the 14-3-3 proteins is their ability to bind a multitude of functionally diverse signaling proteins, including kinases, phosphatases, and transmembrane receptors. This plethora of interacting proteins allows 14-3-3 to play important roles in a wide range of vital regulatory processes, such as mitogenic signal transduction, apoptotic cell death, and cell cycle control. In this review, we examine the structural basis for 14-3-3-ligand interactions, proposed functions of 14-3-3 in various signaling pathways, and emerging views of mechanisms that regulate 14-3-3 actions.
                Bookmark

                Author and article information

                Contributors
                Journal
                Front Cardiovasc Med
                Front Cardiovasc Med
                Front. Cardiovasc. Med.
                Frontiers in Cardiovascular Medicine
                Frontiers Media S.A.
                2297-055X
                26 June 2018
                2018
                : 5
                : 77
                Affiliations
                [1] 1Division of Cardiology, Department of Internal Medicine, Faculty of Medicine, American University of Beirut , Beirut, Lebanon
                [2] 2Department of Genetic Medicine, Weill Cornell Medical College , Doha, Qatar
                [3] 3Department of Biochemistry and Molecular Genetics, Faculty of Medicine, American University of Beirut , Beirut, Lebanon
                Author notes

                Edited by: Fadi N. Salloum, Virginia Commonwealth University, United States

                Reviewed by: Anindita Das, Virginia Commonwealth University, United States; Fadi G. Akar, Icahn School of Medicine at Mount Sinai, United States

                *Correspondence: Marwan M. Refaat mr48@ 123456aub.edu.lb

                This article was submitted to Cardiovascular Genetics and Systems Medicine, a section of the journal Frontiers in Cardiovascular Medicine

                †These authors have contributed equally to this work.

                Article
                10.3389/fcvm.2018.00077
                6028572
                29998127
                1cb14404-34fd-4745-923a-5644ad06770b
                Copyright © 2018 Salman, El-Rayess, Abi Khalil, Nemer and Refaat.

                This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

                History
                : 27 February 2018
                : 04 June 2018
                Page count
                Figures: 0, Tables: 1, Equations: 0, References: 110, Pages: 12, Words: 11396
                Categories
                Cardiovascular Medicine
                Review

                cardiomyopathy,hypertrophic cardiomyopathy,dilated cardiomyopathy,arrythmogenic cardiomyopathy,restrictive cardiomyopathy,spongiform cardiomyopathy,non-coding genome,mutations

                Comments

                Comment on this article